Eric S. Fain

CIK: 0001402222

Transaction Breakdown

Open Market Buys (P)2 (16.7%)

High conviction signal

Open Market Sales (S)4 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OBIO

Orchestra BioMed Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

OBIO
Orchestra BioMed Holdings, Inc.
Aug 12, 2026
Tax Payment(F)
Indirect
5.1K shares at avg. $4.42$23K
OBIO
Orchestra BioMed Holdings, Inc.
Jun 24, 2026
Tax Payment(F)
Indirect
4.3K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Jun 23, 2026
Award(A)
Indirect
17.3K shares-
OBIO
Orchestra BioMed Holdings, Inc.
May 14, 2026
Purchase(P)
Indirect
20K shares at avg. $4.13$83K
OBIO
Orchestra BioMed Holdings, Inc.
Aug 25, 2025
Purchase(P)
Indirect
5.8K shares at avg. $2.61$15K
OBIO
Orchestra BioMed Holdings, Inc.
Aug 7, 2025
Award(A)
Direct
7.5K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Aug 7, 2025
Award(A)
Indirect
7.5K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Jun 26, 2025
Sale(S)
Indirect
2.7K shares at avg. $3.05$8K
OBIO
Orchestra BioMed Holdings, Inc.
Jun 24, 2025
Award(A)
Indirect
12.4K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Sep 10, 2024
Sale(S)
Indirect
1.8K shares at avg. $5.34$10K
OBIO
Orchestra BioMed Holdings, Inc.
Sep 9, 2024
Sale(S)
Indirect
1.8K shares at avg. $5.43$10K
OBIO
Orchestra BioMed Holdings, Inc.
Sep 6, 2024
Sale(S)
Indirect
2K shares at avg. $5.64$11K

		Type	Shares	Price		Ownership
Aug 12, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	5,145	$4.42	$22,741	Indirect
Jun 24, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	4,261	-	$0	Indirect
Jun 23, 2026	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	17,327	-	$0	Indirect
May 14, 2026	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	20,000	$4.13	$82,600	Indirect
Aug 25, 2025	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	5,760	$2.61	$15,034	Indirect
Aug 7, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	7,500	-	-	Direct
Aug 7, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	7,500	-	-	Indirect
Jun 26, 2025	OBIO Orchestra BioMed Holdings, Inc.	Sale(S)	2,683	$3.05	$8,183	Indirect
Jun 24, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	12,422	-	-	Indirect
Sep 10, 2024	OBIO Orchestra BioMed Holdings, Inc.	Sale(S)	1,800	$5.34	$9,612	Indirect
Sep 9, 2024	OBIO Orchestra BioMed Holdings, Inc.	Sale(S)	1,800	$5.43	$9,774	Indirect
Sep 6, 2024	OBIO Orchestra BioMed Holdings, Inc.	Sale(S)	2,000	$5.64	$11,280	Indirect

1-12 of 12 transactions

About Fain Eric S

Fain Eric S (SEC CIK 0001402222) files insider reports with the SEC as Director of Orchestra BioMed Holdings, Inc. (OBIO).

Signal8 holds 8 ownership filings by Fain Eric S, all Form 4s, filed between Sep 10, 2024 and Aug 14, 2026. Those filings report 12 transactions, from Sep 6, 2024 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Fain Eric S's filings is in NEW HOPE, PA.

Recent filings by Fain Eric S

Aug 12, 2026: Tax withholding of OBIO shares (Form 4, code F).
Jun 24, 2026: Tax withholding of OBIO shares (Form 4, code F).
Jun 23, 2026: Grant or award of OBIO shares (Form 4, code A).
May 14, 2026: Open-market purchase of OBIO shares (Form 4, code P).
Aug 25, 2025: Open-market purchase of OBIO shares (Form 4, code P).

Other insiders filing for Orchestra BioMed Holdings, Inc. (OBIO)

Sherman Darren
Hochman David P
Taylor Andrew Lawrence, Chief Financial Officer
Aiello Joshua, Principal Accounting Officer
Pacitti David, Director
Mack John Prosper, Director

How to read Form 4 transaction codes